Your browser doesn't support javascript.
loading
People living with HIV who have poor immune status are a key population for SARS-CoV-2 prevention.
Zhou, Jie; Lan, Liuyan; Ai, Sufang; Lin, Jianyan; Liu, Ningmei; Xie, Yulan; Cui, Ping; Liang, Hao; Ye, Li; Huang, Jiegang; Xie, Zhiman.
Afiliação
  • Zhou J; Guangxi Key Laboratory of AIDS Prevention and Treatment & School of Public Health, Guangxi Medical University, Nanning 530021, Guangxi, China; Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, Nanning 530021, Guangxi, China.
  • Lan L; Guangxi Key Laboratory of AIDS Prevention and Treatment & School of Public Health, Guangxi Medical University, Nanning 530021, Guangxi, China; Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, Nanning 530021, Guangxi, China; The People's Hospital of Guang
  • Ai S; AIDS Clinical Treatment Center of Guangxi (Nanning) & The Fourth People's Hospital of Nanning, Nanning 530012, Guangxi, China.
  • Lin J; AIDS Clinical Treatment Center of Guangxi (Nanning) & The Fourth People's Hospital of Nanning, Nanning 530012, Guangxi, China.
  • Liu N; AIDS Clinical Treatment Center of Guangxi (Nanning) & The Fourth People's Hospital of Nanning, Nanning 530012, Guangxi, China.
  • Xie Y; Guangxi Key Laboratory of AIDS Prevention and Treatment & School of Public Health, Guangxi Medical University, Nanning 530021, Guangxi, China; Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, Nanning 530021, Guangxi, China.
  • Cui P; Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, Nanning 530021, Guangxi, China; Life Science Institute, Guangxi Medical University, Nanning 530021, Guangxi, China.
  • Liang H; Guangxi Key Laboratory of AIDS Prevention and Treatment & School of Public Health, Guangxi Medical University, Nanning 530021, Guangxi, China; Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, Nanning 530021, Guangxi, China; Life Science Institute, Guangx
  • Ye L; Guangxi Key Laboratory of AIDS Prevention and Treatment & School of Public Health, Guangxi Medical University, Nanning 530021, Guangxi, China; Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, Nanning 530021, Guangxi, China; Life Science Institute, Guangx
  • Huang J; Guangxi Key Laboratory of AIDS Prevention and Treatment & School of Public Health, Guangxi Medical University, Nanning 530021, Guangxi, China; Guangxi Universities Key Laboratory of Prevention and Control of Highly Prevalent Disease, Nanning 530021, Guangxi, China.
  • Xie Z; AIDS Clinical Treatment Center of Guangxi (Nanning) & The Fourth People's Hospital of Nanning, Nanning 530012, Guangxi, China. Electronic address: 20060830xzm@163.com.
J Infect ; 88(3): 106122, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38367706
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / COVID-19 Limite: Humans Idioma: En Revista: J Infect Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / COVID-19 Limite: Humans Idioma: En Revista: J Infect Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China